SCHEMBL6315837

SCHEMBL6315837

O=C(O)C(=O)Nc1sc2c(c1C(=O)O)CC(CNC(=O)c1ccco1)OC2

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.53
HPGD P15428 6/20 0.53
SMN1; SMN2 Q16637 4/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
PKM P14618 1/20 0.53
ALDH1A1 P00352 6/20 0.52
NPC1 O15118 5/20 0.52
RAB9A P51151 5/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
TP53 P04637 1/20 0.52
RAB7A P51149 3/20 0.49
ANO1 Q5XXA6 1/20 0.49
PTPN1 P18031 5/20 0.44
PTPN2 P17706 3/20 0.43
PTPRC P08575 1/20 0.43
PTPRB P23467 1/20 0.43
PTPRE P23469 1/20 0.43
FLT3 P36888 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6206528 0.87 RAB7A (0.55) MAPTHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL6316036 0.85 PTPN1 (0.47) MAPTSMN1; SMN2ALDH1A1LMNATP53
SCHEMBL6322930 0.85 PTPN1 (0.47) MAPTSMN1; SMN2ALDH1A1LMNARAB7A
SCHEMBL6315228 0.83 PTPN1 (0.43) MAPTHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL6317364 0.83 LMNA (0.52) MAPTHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL6316165 0.83 PTPN1 (0.48) MAPTSMN1; SMN2ALDH1A1LMNARAB7A
SCHEMBL6314369 0.83 MAPT (0.57) MAPTHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL7159868 0.83 HPGD (0.47) MAPTHPGDSMN1; SMN2MEN1KMT2A
SCHEMBL6207392 0.82 MAPT (0.56) MAPTLMNATP53PTPN1POLB
SCHEMBL6315979 0.82 MEN1 (0.54) MAPTMEN1KMT2AALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) MOLLER NIELS PETER HUNDAHL (DK) 2003-04-10 US claimed
US-6951878-B2 Benzo[b]thiophenyl or tetrahydro-benzo[b]thiophenyl modulators of protein tyrosine phosphatases (PTPases) NOVO NORDISK A/S (DK) 2005-10-04 US disclosed
US-6410586-B1 ANTICOAGULANTS; INSULIN RESISTANCE; ANTIALLERGENS NOVO NORDISK A/S (DK) 2002-06-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030069267-A1 Modulators of protein tyrosine phosphatases (PTPases) PTPRCAP, PTPRS, PTPRA MAPT 475/4885HPGD 2593/4885SMN1; SMN2 1576/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.